fabkin that enhances metabolic health. This hormone may contribute to both type 1 and type 2 diabetes, according to research led by the Sabri Ülker Center for Metabolic Research at Harvard T.H.
Chan School of Public Health.The study found that mice and human patients with either type 1 or 2 diabetes had abnormally high blood levels of fabkin.
Researchers discovered that inhibiting fabkin activity stopped the development of both types of diabetes in the mice. The team found that fabkin behaves similarly in humans and believes that the hormone could lead to new medical treatments.
Read more on powerofpositivity.com